Identification and development of oxoquinazoline derivatives as novel mycobacterial inhibitors targeting cell wall synthesis enzyme

Background: Tuberculosis (TB) still remains the leading cause of death worldwide and was unanswered till date. Available treatment strategies have many drawbacks such as longer treatment period, side effects, and drug interactions, which result in patient noncompliance. In the present work, we thriv...

Full description

Bibliographic Details
Main Authors: Prasanthi Malapati, Krishna Siva Vagolu, Dhramarajan Sriram
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2018-01-01
Series:Biomedical and Biotechnology Research Journal
Subjects:
Online Access:http://www.bmbtrj.org/article.asp?issn=2588-9834;year=2018;volume=2;issue=1;spage=31;epage=38;aulast=Malapati